NEO News and Press, NeoGenomics Inc. From 12/19/23

2023-12-19 16:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

FT. MYERS, FL / ACCESSWIRE / December 5, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading oncology testing services company, today announced new data highlighting its RaDaR ® assay for minimal residual disease (MRD) will be presented at the 46 th annual San Antonio Breast Cancer Symposi...

FT. MYERS, FL / ACCESSWIRE / November 14, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading oncology testing services company, today announced the company will participate in the upcoming Piper Sandler 35 th Annual Global Healthcare Conference in New York City. Members of NeoGenomics' managemen...

2023-11-06 20:03:03 ET NeoGenomics, Inc (NEO) Q3 2023 Earnings Conference Call November 6, 2023 04:30 AM ET Company Participants Kendra Sweeney - VP, IR Chris Smith - CEO Jeff Sherman - CFO Vishal Sikri - President, Advanced Diagnostics Warren Stone - Pre...

2023-11-06 16:46:59 ET NeoGenomics press release ( NASDAQ: NEO ): Q3 Non-GAAP EPS of $0.00 beats by $0.08 . Revenue of $152M (+18.0% Y/Y) beats by $10M . Raised 2023 revenue guidance to a range of $585 million - $592 million. For further details see: ...

Third Quarter Revenue Increased 18% to $152 Million FORT MYERS, FL / ACCESSWIRE / November 6, 2023 / NeoGenomics, Inc. (NASDAQ:NEO) (the " Company " ), a leading oncology testing services company, today announced its third-quarter results for the period ended September 30, 2023 as compared ...

CGG ADR (CGGYY) is expected to report for quarter end 2023-09-30 ATI Physical Therapy Inc. Class A (ATIP) is expected to report $-4.08 for Q3 2023 Riot Platforms Inc. (RIOT) is expected to report $-0.29 for Q3 2023 Bain Capital Specialty Finance Inc. (BCSF) is expected to report $0.57...

NeoGenomics Inc. (NEO) is expected to report $-0.11 for Q3 2023

2023-11-05 17:35:55 ET Major earnings expected after the bell on Monday include: Realty Income Corporation ( O ) Vertex Pharmaceuticals Incorporated ( VRTX ) NXP Semiconductors N.V. ( NXPI ) Alteryx ( AYX ) Tanger Factory Outlet Centers ( SKT ) ...

2023-10-25 06:30:00 ET Summary NeoGenomics, Inc. has caught a bid in recent weeks, reversing off this year's lows. The market has priced a high required rate of return for buying NeoGenomics today, indicating a substantial degree of implied risk. The company's economic charact...